{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:39:42Z","timestamp":1725971982390},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T00:00:00Z","timestamp":1260921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12032-009-9385-7","type":"journal-article","created":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T19:40:45Z","timestamp":1260906045000},"page":"1336-1339","source":"Crossref","is-referenced-by-count":1,"title":["Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia"],"prefix":"10.1007","volume":"27","author":[{"given":"A.","family":"Alonci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Penna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,16]]},"reference":[{"key":"9385_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI200113560","volume":"108","author":"RV Iozzo","year":"2001","unstructured":"Iozzo RV. Heparan sulphate proteoglycans: intricate molecules with intriguing functions. J Clin Invest. 2001;108:165\u20137.","journal-title":"J Clin Invest"},{"key":"9385_CR2","first-page":"5210","volume":"62","author":"H Joensuu","year":"2002","unstructured":"Joensuu H, et al. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factor in lung cancer. Cancer Res. 2002;62:5210\u20137.","journal-title":"Cancer Res"},{"key":"9385_CR3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V95.2.388","volume":"95","author":"C Seidel","year":"2000","unstructured":"Seidel C, Sundan A, Hjorth M. Serum syndecan-1: a new independent parameter in multiple myeloma. Blood. 2000;95:388\u201392.","journal-title":"Blood"},{"key":"9385_CR4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/10428190500470358","volume":"47","author":"S Molica","year":"2006","unstructured":"Molica S, et al. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease. Leuk Lymphoma. 2006;47:1034\u201340.","journal-title":"Leuk Lymphoma"},{"key":"9385_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1751-553X.2007.01010.x","volume":"31","author":"I Jilani","year":"2009","unstructured":"Jilani I, et al. Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia. Int J Lab Hematol. 2009;31:97\u2013105.","journal-title":"Int J Lab Hematol"},{"key":"9385_CR6","first-page":"23","volume":"4","author":"D Wo\u0142owiec","year":"2006","unstructured":"Wo\u0142owiec D, Dybko J, Wr\u00f3bel T, Urbaniak-Kujda D, Ja\u017awiec B, Tomaszewska-Toporska B, et al. Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage b-cell chronic lymphocytic leukemia. Mediators Inflamm. 2006;4:23\u20134.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"9385_CR7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2141.1999.01211.x","volume":"104","author":"A Sebestyen","year":"1999","unstructured":"Sebestyen A, et al. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas. Br J Haematol. 1999;104(2):412\u20139.","journal-title":"Br J Haematol"},{"issue":"1\u20132","key":"9385_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/10428199809057596","volume":"31","author":"TE Witzig","year":"1998","unstructured":"Witzig TE, Kimlinger T, Stenson M, Therneau T. Syndecan- 1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and Bcell chronic lymphocytic leukemia. Leuk Lymphoma. 1998;31(1\u20132):167\u201375.","journal-title":"Leuk Lymphoma"},{"key":"9385_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ijc.10930","volume":"104","author":"D Marchetti","year":"2003","unstructured":"Marchetti D, Reiland J, Erwin B, Roy M. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues. Int J Cancer. 2003;104:167\u201374.","journal-title":"Int J Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9385-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9385-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T07:54:52Z","timestamp":1590306892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9385-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,16]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9385"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9385-7","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,16]]}}}